Capital Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$739K Sell
10,269
-1,035
-9% -$78K 1.02% 35
2022
Q3
$804K Buy
11,304
+75
+0.7% +$5.44K 1.19% 32
2022
Q2
$865K Sell
11,229
-400
-3% -$30.5K 1.22% 34
2022
Q1
$849K Buy
11,629
+150
+1% +$10.1K 1% 35
2021
Q4
$716K Sell
11,479
-150
-1% -$8.8K 0.78% 43
2021
Q3
$688K Buy
11,629
+170
+1% +$11.2K 0.84% 41
2021
Q2
$766K Sell
11,459
-35
-0.3% -$2.28K 0.97% 37
2021
Q1
$726K Buy
11,494
+525
+5% +$32.7K 0.97% 36
2020
Q4
$680K Buy
+10,969
New +$674K 0.95% 36

Other funds holding BMY

Capital Financial Services's BMY Position: Q4 2022 in Review

Capital Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q4 2022, selling an estimated $78K and leaving 10,269 shares worth $739K. The position accounts for 1.02% of the portfolio, ranked #35.

Capital Financial Services first reported a position in BMY in Q4 2020 and has held it in 9 quarters since. The position peaked at $865K in Q2 2022. 2,600 funds tracked by Wall St. Rank hold BMY as of Q4 2022.

  • Capital Financial Services held 10,269 shares of Bristol-Myers Squibb worth $739K as of Q4 2022.
  • Capital Financial Services sold 1,035 Bristol-Myers Squibb shares in Q4 2022, an estimated $78K.
  • Bristol-Myers Squibb made up 1.02% of Capital Financial Services's portfolio in Q4 2022, its #35 holding.
  • Capital Financial Services first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 9 quarters since.
  • Capital Financial Services's Bristol-Myers Squibb position peaked at $865K in Q2 2022.
  • 2,600 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.